Corbus Pharmaceuticals Holdings (CRBP) Operating Expenses (2013 - 2025)

Corbus Pharmaceuticals Holdings' Operating Expenses history runs 13 years deep, the most recent figure standing at $24.4 million for Q3 2025.

• In Q3 2025, Operating Expenses rose 57.48% year-over-year to $24.4 million; the TTM figure through Dec 2025 stood at $63.3 million (up 30.01% YoY), while the FY2024 annual figure was $48.7 million, up 8.08% from the prior year.
• Operating Expenses was $24.4 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $19.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $24.4 million in Q3 2025 to a low of $8.2 million in Q3 2022.
• Historically, Operating Expenses has averaged $13.4 million across 5 years, with a median of $12.3 million in 2022.
• The sharpest annual moves came in 2021 and 2025: Operating Expenses plunged 60.31% in 2021, then surged 105.5% in 2025.
• A 5-year view of Operating Expenses shows it stood at $10.0 million in 2021, then advanced by 7.99% to $10.8 million in 2022, then fell by 6.42% to $10.1 million in 2023, then rose by 24.75% to $12.6 million in 2024, then soared by 93.71% to $24.4 million in 2025.
• The last three Operating Expenses figures came in at $24.4 million (Q3 2025), $19.2 million (Q2 2025), and $19.8 million (Q1 2025), per Business Quant data.